Page last updated: 2024-11-08

1,4-dichloro-2-butene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,4-dichloro-2-butene: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID642197
CHEMBL ID468582
CHEBI ID82446
SCHEMBL ID205123
MeSH IDM0056427

Synonyms (85)

Synonym
LS-12983
(e)-1,4-dichloro-but-2-ene
2-butene, 1,4-dichloro-
trans-1,4-dichlorobutene-2
(2e)-1,4-dichlorobut-2-ene
2-butene, 1,4-dichloro-, (2e)-
1,4-dichlorobutene-2 (65% trans-, 35% cis-)
1,4-dichloro-2-butylene
brn 1361446
einecs 212-121-8
1,4-dichlorobutene-2
nsc 9452
rcra waste number u074
rcra waste no. u074
hsdb 6008
2-butylene dichloride
1,4-dcb
ccris 2458
1,4-dichloro-trans-2-butene
2-butene, 1,4-dichloro-, trans-
ai3-52332
brn 1719693
hsdb 1501
trans-1,4-dichlorobutene
einecs 203-779-7
(e)-1,4-dichloro-2-butene
1,4-dichloro-2-butene
764-41-0
2-butene, 1,4-dichloro-, (e)-
trans-1,4-dichloro-2-butene
110-57-6
NCGC00091067-01
inchi=1/c4h6cl2/c5-3-1-2-4-6/h1-2h,3-4h2/b2-1
GHL.PD_MITSCHER_LEG0.1064
trans-1,4-dichloro-2-butene, technical grade, 85%, remainder predominantly cis isomer
trans-1,4-dichloro-2-butene, 98%
(e)-1,4-dichlorobut-2-ene
D1624
chebi:82446 ,
CHEMBL468582
A802220
(e)-1,4-bis(chloranyl)but-2-ene
NCGC00091067-03
NCGC00091067-02
AKOS009157402
C19398
dtxsid6020434 ,
NCGC00257573-01
dtxcid20434
tox21_200451
tox21_200019
dtxsid9027310 ,
cas-110-57-6
cas-764-41-0
NCGC00258005-01
dtxcid4028123
92hz946h7y ,
4-01-00-00787 (beilstein handbook reference)
unii-92hz946h7y
ccris 8948
1,4-dichloro-2-butene, trans-
trans-1,4-dichlorobuten-2-ene
1,4-dichloro-trans-2-butene [hsdb]
1,4-dichloro-2-butene, (2e)-
1,4-dichloro-2-butene (cis+trans)
BP-30086
SCHEMBL205123
mfcd00000988
trans 1,4-dichlorobutene-2
1,4-dichloro(trans) 2-butene
1,4-dichloro-2-butene, trans
1,4-dichloro-(e)-2-butene
(2e)-1,4-dichloro-2-butene #
1,4-dichlorobutene-2, (e)-
1,4-dichloro-2-but-2-ene
EN300-41991
BBL102602
trans-1,4-dichlorobut-2-ene
STL556405
Q4545691
tri-1,4-dichloro-2-butene
trans-1,4-dichloro-but-2-ene
AMY2667
MS-20466
EN300-306610

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"This study was conducted to elucidate the time- and dose-response relationships of long-term, low-level 1,4-dichlorobutene-2 (DCB) inhalation exposure to nasal tumor induction in rats."( Nasal tumors in rats following long-term inhalation exposure to 1,4-dichlorobutene-2 (DCB).
Kennedy, GL; Mullin, LS; Wood, CK, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency17.78280.004023.8416100.0000AID485290
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
RAR-related orphan receptor gammaMus musculus (house mouse)Potency38.76700.006038.004119,952.5996AID1159523
AR proteinHomo sapiens (human)Potency42.43310.000221.22318,912.5098AID743036; AID743040; AID743042
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency24.52280.000214.376460.0339AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency41.00420.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.16300.000229.305416,493.5996AID743080
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.38880.001723.839378.1014AID743083
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.05450.000627.21521,122.0200AID651741; AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID384212Mutagenic activity in Salmonella Typhimurium TA100 assessed as logarithm of his+ revertant number increasing activity by amens test2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (50.00)18.7374
1990's2 (16.67)18.2507
2000's4 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.05 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index36.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]